WO2007025764A3 - Pharmazeutische formulierung für salze monobasischer säuren mit clopidogrel - Google Patents
Pharmazeutische formulierung für salze monobasischer säuren mit clopidogrel Download PDFInfo
- Publication number
- WO2007025764A3 WO2007025764A3 PCT/EP2006/008539 EP2006008539W WO2007025764A3 WO 2007025764 A3 WO2007025764 A3 WO 2007025764A3 EP 2006008539 W EP2006008539 W EP 2006008539W WO 2007025764 A3 WO2007025764 A3 WO 2007025764A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- clopidogrel
- salts
- pharmaceutical formulations
- monobasic acids
- monobasic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Die vorliegende Erfindung betrifft eine pharmazeutische Formulierung in Form einer Tablette, die als Wirkstoff ein Salz einer monobasischen Säure mit Clopidogrel enthält.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE202005013839U DE202005013839U1 (de) | 2005-09-01 | 2005-09-01 | Pharmazeutische Formulierung für Salze monobasischer Säuren mit Clopidogrel |
DE202005013839.8 | 2005-09-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007025764A2 WO2007025764A2 (de) | 2007-03-08 |
WO2007025764A3 true WO2007025764A3 (de) | 2007-08-16 |
Family
ID=35268002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/008539 WO2007025764A2 (de) | 2005-09-01 | 2006-08-31 | Pharmazeutische formulierung für salze monobasischer säuren mit clopidogrel |
Country Status (3)
Country | Link |
---|---|
US (1) | US20070048370A1 (de) |
DE (1) | DE202005013839U1 (de) |
WO (1) | WO2007025764A2 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100400035C (zh) * | 2006-10-18 | 2008-07-09 | 深圳信立泰药业股份有限公司 | 氯吡格雷硫酸盐的固体制剂及其制备方法 |
EP1970054A3 (de) * | 2007-03-14 | 2009-06-03 | Ranbaxy Laboratories Limited | Clopidogrel-Tabletten |
EP2148655B1 (de) * | 2007-04-20 | 2013-02-27 | Wockhardt Limited | Pharmazeutische zusammensetzungen von clopidogrel |
WO2010009745A1 (en) * | 2008-07-25 | 2010-01-28 | Pharmathen S.A. | Solid oral dosage form containing anti-platelet agent clopidogrel and method for the preparation thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004074215A1 (en) * | 2003-02-03 | 2004-09-02 | Sunil Sadanand Nadkarni | Process for preparation of clopidogrel, its salts and pharmaceutical compositions |
WO2005048992A1 (en) * | 2003-11-03 | 2005-06-02 | Sandoz Ag | Process for preparing clopidogrel compositions |
-
2005
- 2005-09-01 DE DE202005013839U patent/DE202005013839U1/de not_active Expired - Lifetime
-
2006
- 2006-03-30 US US11/392,824 patent/US20070048370A1/en not_active Abandoned
- 2006-08-31 WO PCT/EP2006/008539 patent/WO2007025764A2/de active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004074215A1 (en) * | 2003-02-03 | 2004-09-02 | Sunil Sadanand Nadkarni | Process for preparation of clopidogrel, its salts and pharmaceutical compositions |
WO2005048992A1 (en) * | 2003-11-03 | 2005-06-02 | Sandoz Ag | Process for preparing clopidogrel compositions |
Also Published As
Publication number | Publication date |
---|---|
DE202005013839U1 (de) | 2005-10-27 |
US20070048370A1 (en) | 2007-03-01 |
WO2007025764A2 (de) | 2007-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007014124A3 (en) | High drug load formulations and dosage forms | |
WO2011012816A3 (fr) | Formulation pharmaceutique | |
WO2010065709A3 (en) | Hydroxamic acid derivatives, preparation and therapeutic uses thereof | |
WO2011003853A3 (en) | Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient | |
WO2008131114A3 (en) | Pharmaceutical formulations containing lipoic acid derivatives | |
IL195269A0 (en) | Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic | |
EP2340821A4 (de) | Mittel zur prophylaxe/linderung von erwachsenenkrankheiten mit 5-aminolevulinsäure, einem 5-aminolevulinsäure-derivat oder einem 5-aminolevulinsäure-salz oder 5-aminolevulinsäure-derivat als wirkstoff | |
WO2012021715A3 (en) | Stable formulations of linaclotide | |
WO2009117130A3 (en) | Extended release forumulation containing a wax | |
WO2004072085A3 (de) | Salz einer sulfonsäure mit clopidogrel und dessen verwendung zur herstellung pharmazeutischer formulierungen | |
WO2010021607A3 (en) | Pharmaceutical formulation | |
EP2045253A4 (de) | alpha-AMINOSÄUREDERIVAT UND PHARMAZEUTIKUM, DAS DIESES ALS WIRKSTOFF ENTHÄLT | |
WO2008052033A3 (en) | Ibuprofen composition | |
WO2006128600A3 (de) | Stabiler wirkstoffkomplex von salzen der o-acetylsalicylsäure mit basischen aminosäuren und glycin | |
WO2010072958A3 (fr) | Composition pharmaceutique topique comprenant un principe actif sensible a l'eau | |
WO2009135593A3 (de) | Feste arzneimittelformulierung mit verzögerter freisetzung | |
WO2007090661A3 (en) | Active substance combination comprising azolylcarbinol compounds | |
UA96622C2 (ru) | Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования | |
WO2006129237A3 (en) | Novel piperidine carboxylic acid amide derivatives | |
WO2008001201A3 (en) | Pharmaceutical compositions of clopidogrel | |
WO2011002422A3 (en) | Solubility enhancing pharmaceutical formulation | |
WO2009095624A3 (fr) | Procede de preparation d'acides dicafeoylquiniques et leur utilisation dans la lutte contre les pucerons | |
WO2007025764A3 (de) | Pharmazeutische formulierung für salze monobasischer säuren mit clopidogrel | |
EP2212325A4 (de) | 2-arylmethylazetidincarbapenem-3-carbonsäureesterderivat oder dessen salz, verfahren zur herstellung davon und dieses enthaltende pharmazeutische zusammensetzung | |
WO2007002128A3 (en) | Compositions comprising and processes for producing inorganic salts of hop acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06777136 Country of ref document: EP Kind code of ref document: A2 |